Scarica l'app Stockscreener
30.36
6.79%
1.93
Dopo l'orario di chiusura:
30.86
0.50
+1.65%
Precedente Chiudi:
$28.43
Aprire:
$28.9
Volume 24 ore:
4.24M
Relative Volume:
2.83
Capitalizzazione di mercato:
$11.15B
Reddito:
$520.18M
Utile/perdita netta:
$-348.13M
Rapporto P/E:
-15.81
EPS:
-1.92
Flusso di cassa netto:
$-176.18M
1 W Prestazione:
+7.32%
1M Prestazione:
-8.47%
6M Prestazione:
-28.48%
1 anno Prestazione:
-26.56%
Intervallo 1D:
$28.78
$32.45
Intervallo di 1 settimana:
$27.98
$32.45
Portata 52W:
$27.34
$60.87
Legend Biotech Corp Adr Stock (LEGN) Company Profile
Nome
Legend Biotech Corp Adr
Settore
Industria
Telefono
-
Indirizzo
-
Confronta LEGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LEGN
Legend Biotech Corp Adr
|
30.36 | 5.21B | 520.18M | -348.13M | -176.18M | -1.92 |
|
ONC
Beone Medicines Ltd Adr
|
258.27 | 26.01B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
445.85 | 114.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.3499 | 41.83M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
83.98 | 6.29B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
484.93 | 63.90B | 14.09B | 4.50B | 2.96B | 39.28 |
Legend Biotech Corp Adr Stock (LEGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-08 | Iniziato | Redburn Atlantic | Buy |
| 2024-06-17 | Iniziato | Truist | Buy |
| 2024-05-24 | Reiterato | H.C. Wainwright | Buy |
| 2024-05-23 | Iniziato | Deutsche Bank | Buy |
| 2024-04-17 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2024-04-03 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-03-13 | Iniziato | Raymond James | Outperform |
| 2023-12-19 | Iniziato | Scotiabank | Sector Perform |
| 2023-11-06 | Iniziato | Goldman | Buy |
| 2023-05-25 | Iniziato | William Blair | Mkt Perform |
| 2023-05-22 | Iniziato | Daiwa Securities | Buy |
| 2023-03-29 | Iniziato | H.C. Wainwright | Buy |
| 2023-03-24 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-12-06 | Iniziato | UBS | Buy |
| 2022-11-02 | Iniziato | Evercore ISI | Outperform |
| 2022-11-01 | Iniziato | Cowen | Outperform |
| 2022-10-31 | Iniziato | Guggenheim | Neutral |
| 2022-06-17 | Iniziato | BMO Capital Markets | Outperform |
| 2022-03-15 | Iniziato | Barclays | Overweight |
| 2022-01-31 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-06 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-21 | Iniziato | Piper Sandler | Overweight |
| 2021-05-18 | Iniziato | BTIG Research | Buy |
| 2020-07-01 | Iniziato | JP Morgan | Overweight |
| 2020-07-01 | Iniziato | Jefferies | Buy |
| 2020-06-30 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Legend Biotech Corp Adr Borsa (LEGN) Ultime notizie
RBC Capital maintains outperform rating on Legend Biotech stock By Investing.com - Investing.com South Africa
RBC Capital maintains outperform rating on Legend Biotech stock - Investing.com India
BMO Capital reaffirms outperform rating on Legend Biotech stock By Investing.com - Investing.com South Africa
BMO Capital reaffirms outperform rating on Legend Biotech stock - Investing.com
Legend Biotech’s SWOT analysis: carvykti drives growth as stock faces competition - Investing.com India
RBC Capital maintains Legend Biotech at outperform with $78 target By Investing.com - Investing.com South Africa
RBC Capital maintains Legend Biotech at outperform with $78 target - Investing.com
AbbVie, Nvidia, and Exelixis Lead Market Cap Stock Movers on Wednesday By Investing.com - Investing.com South Africa
AbbVie, Nvidia, and Exelixis Lead Market Cap Stock Movers on Wednesday - Investing.com
Truist cuts Legend Biotech stock target to $71, maintains buy rating - Investing.com India
Legend Biotech stock holds $62 target, solid Carvykti sales growth By Investing.com - Investing.com India
Legend Biotech stock holds $62 target, solid Carvykti sales growth - Investing.com
Raymond James maintains Legend Biotech Outperform rating - Investing.com
Raymond James maintains Legend Biotech Outperform rating By Investing.com - Investing.com UK
Earnings call transcript: Legend Biotech Q1 2025 sees strong CARVICTI sales boost - Investing.com India
Legend Biotech Q1 2025 slides: CARVYKTI sales surge 135% as path to profitability clarifies - Investing.com India
Legend Biotech Reports First Quarter 2025 Results and Recent Highlights - GlobeNewswire Inc.
Stock Surge: Legend Biotech Corp ADR (LEGN) Closes at 31.37, Marking a -6.08 Increase/Decrease - DWinneX
What Makes Legend Biotech (LEGN) a New Buy Stock - Yahoo Finance
Wall Street Analysts Think Legend Biotech (LEGN) Could Surge 135.16%: Read This Before Placing a Bet - Yahoo Finance
Top investors say Legend Biotech Corp ADR (LEGN) ticks everything they need - Sete News
LEGN stock rated a Buy by Redburn Atlantic - knoxdaily.com
Taking a look at what insiders are doing to gauge the Legend Biotech Corp ADR (LEGN)’s direction - knoxdaily.com
Selling Buzz: Graphjet Technology [GTI] 10% Owner SURIA SUKSES ENGINEERING SDN B sells 2,490,517 shares of the company – Knox Daily - knoxdaily.com
UP Fintech Holding Ltd ADR [TIGR] Records 200-Day SMA of $6.22 - knoxdaily.com
UEC Stock Sees Surge of Approximately 9.34% in Last Five Days - knoxdaily.com
Vir Biotechnology Inc [VIR] Records 200-Day SMA of $8.24 - knoxdaily.com
Arm Holdings plc. ADR [ARM] Officer makes an insider purchase of 9,220 shares worth 1.41 million. - knoxdaily.com
Valero Energy Corp [VLO] Records 200-Day SMA of $134.80 - knoxdaily.com
KE Holdings Inc ADR [BEKE] Records 200-Day SMA of $18.54 - knoxdaily.com
Celestica, Inc [NYSE: CLS] Sees Increase in Stock Value - knoxdaily.com
Perimeter Solutions Inc [PRM] Records 50-Day SMA of $9.97 - knoxdaily.com
JBI Shares Experience Surge in Value - knoxdaily.com
CRGY Shares Experience Surge in Value - knoxdaily.com
Gannett Co Inc [GCI] Records 200-Day SMA of $4.65 - knoxdaily.com
Jamf Holding Corp [JAMF] Shares Rise 5.68 % on Thursday - knoxdaily.com
Mirion Technologies Inc [MIR] Records 200-Day SMA of $13.95 - knoxdaily.com
Vista Energy S.A.B. de C.V ADR [NYSE: VIST] Sees Increase in Stock Value - knoxdaily.com
Ares Management Corp [ARES] stock for 16,977,649 USD was sold by Arougheti Michael J - knoxdaily.com
Banc of California Inc [BANC] Records 50-Day SMA of $13.98 - knoxdaily.com
HSAI Shares Experience Surge in Value - knoxdaily.com
QXO Stock Sees Decline of Approximately -10.59% in Last Five Days - knoxdaily.com
Blue Owl Capital Inc [OWL] Controlled affiliate makes an insider purchase of 1,817,382 shares worth 39.13 million. - knoxdaily.com
Lennar Corp [NYSE: LEN] Sees Increase in Stock Value - knoxdaily.com
Vertiv Holdings Co [NYSE: VRT] Sees Increase in Stock Value - knoxdaily.com
XPeng Inc ADR [XPEV] Records 200-Day SMA of $13.46 - knoxdaily.com
Zurn Elkay Water Solutions Corp [NYSE: ZWS] Sees Increase in Stock Value - knoxdaily.com
Pegasystems Inc [PEGA] Shares Jump Approximately 57.05% Over the Year - knoxdaily.com
A company insider recently sold 50,000 shares of Iovance Biotherapeutics Inc [IOVA]. Should You Sale? - knoxdaily.com
Cameco Corp [CCJ] Officer makes an insider purchase of 50,000 shares worth 3.06 million. - knoxdaily.com
Sea Ltd ADR [SE] Shares Rise 3.14 % on Thursday - knoxdaily.com
Legend Biotech Corp Adr Azioni (LEGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.00%
0.54%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):